November 11, 2013

Targeting TNF-α for the treatment of inflammatory bowel disease

TBThomas BillietAZ Groeninge

Paul RutgeertsUniversity of Leeds MFMarc FerranteUniversitair Ziekenhuis Leuven

Key Points

Key points are not available for this paper at this time.

Abstract

TNF antagonists have become indispensable in the management of IBD. Efforts to focus on treatment of inflammatory signs only and on optimization of treatment with therapeutic drug monitoring are underway. The advent of several new compounds and "biosimilars" will further challenge the position of TNF antagonists in the treatment algorithm of IBD.

KI fragen

Bookmark

View Full Paper

Cite This Study

Billiet et al. (Mon,) studied this question.

synapsesocial.com/papers/69dee7f692a5e9426ae93d16 https://doi.org/https://doi.org/10.1517/14712598.2014.858695

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper